Bristol Myers Squibb and Pfizer launch direct-to-patient Eliquis program
Go back to Bristol Myers Squibb and Pfizer launch direct-to-patient Eliquis program| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 55.00 -0.53 (0.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.53 | 52 Week High | $77.12 | |||
| Open | $56.00 | 52 Week Low | $49.03 | |||
| Day High | $56.59 | P/E | 35.71 | |||
| Day Low | $54.78 | EPS | $1.54 | |||
| Volume | 18,905,679 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 24.04 -0.68 (2.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.72 | 52 Week High | $37.39 | |||
| Open | $24.80 | 52 Week Low | $28.25 | |||
| Day High | $25.11 | P/E | 14.57 | |||
| Day Low | $23.93 | EPS | $1.65 | |||
| Volume | 76,926,336 | |||||
